Evidence map›Paper›PMID 35011324›Full record

ArticleMolecules (Basel, Switzerland)2021

Determination of the Peptide AWRK6 in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) and Its Application to Pharmacokinetics.

Lili Jin, Haibo Ding, Volkan Degirmenci, Hongchuan Xin, Qifan Miao, Qiuyu Wang, Dianbao Zhang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Lili JinSchool of Life Sciences, Liaoning University, Shenyang 110036, China.
Haibo DingSchool of Life Sciences, Liaoning University, Shenyang 110036, China.ORCID 0000-0003-3236-1049
Volkan DegirmenciSchool of Engineering, University of Warwick, Coventry CV4 7AL, UK.ORCID 0000-0003-2550-1875
Hongchuan XinQingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China.
Qifan MiaoSchool of Life Sciences, Liaoning University, Shenyang 110036, China.
Qiuyu WangSchool of Life Sciences, Liaoning University, Shenyang 110036, China.
Dianbao ZhangDepartment of Stem Cells and Regenerative Medicine, China Medical University, Shenyang 110122, China.ORCID 0000-0001-7063-7742
Liaoning University · CNChinese Academy of Sciences · CNMinistry of Education of the People's Republic of China · CNUniversity of Warwick · GB

Funding

National Natural Science Foundation of China 32171532National Natural Science Foundation of China 82073419
6 · The paper itself

Abstract

AWRK6 was a synthesized peptide developed based on the natural occurring peptide dybowskin-2CDYa, which was discovered in frog skin in our previous study. Here, a quantitative determination method for AWRK6 analysis in rat plasma by using liquid chromatography-tandem mass spectrometry (LC-MS/MS) was established and validated following U.S. FDA guidelines. A combination of plasma precipitation and liquid-liquid extraction was applied for the extraction. For pharmacokinetics study, the rats were administrated with AWRK6 via intraperitoneal and intravenous injection. The prepared plasma samples were separated on an ODS column and analyzed by tandem MS using precursor-to-product ion pairs of

Indexed as

Chromatography, LiquidDrug MonitoringTandem Mass SpectrometryAnimalsBiological AvailabilityDrug StabilityKineticsPeptidesRatsReproducibility of ResultsAWRK6 peptidePeptidesAWRK6LC-MS/MSpeptidepharmacokineticsrat

Identifiers

PMID35011324
PMCPMC8746970
OpenAlexW4205934410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.